Rna Pharma, LLC

Form 483 issued March 8, 2024 · Blue Island, Illinois

Inspection
Mar 6 – Mar 8, 2024
Investigator
Peng Zhou
Observations
4
Pages
4
FEI number
1000114834

In short: On March 8, 2024, FDA issued a Form 483 with 4 observations to Rna Pharma, LLC in Blue Island, Illinois (FEI 1000114834) after an inspection that ran Mar 6 – Mar 8, 2024. The investigator was Peng Zhou. Most observations concern facilities & equipment and production.

At a glance

Facilities & equipment and production account for 3 of 4 observations.

Facilities & equipment2
Production1
Quality system1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Appropriate controls are not exercised over computers or related systems to assure that changes in master…

  2. 02

    Procedures designed to prevent objectionable microorganisms in drug products not required to be…

  3. 03

    The responsibilities and procedures applicable to the quality control unit…

  4. 04

    Buildings used in the manufacture, processing, packing, or holding of a ding product do not have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Rna Pharma, LLC?

FDA listed 4 observations on this Form 483, mostly about facilities & equipment, production and quality system. The opening words of each observation are shown on this page.

Who inspected Rna Pharma, LLC?

Peng Zhou is named on this Form 483, for the inspection of Mar 6 – Mar 8, 2024. Each investigator has a profile showing what they cite most.

When was Rna Pharma, LLC inspected by FDA?

The inspection ran Mar 6 – Mar 8, 2024, and the Form 483 is dated March 8, 2024.

How do I get the full Form 483 for Rna Pharma, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free